Insilico’s Alex Aliper to Attend Two Hong Kong Summits on AI Healthcare
Alex Aliper, PhD, Co-founder and President of Insilico Medicine, is set to bring the rapidly evolving science of generative artificial ...
Alex Aliper, PhD, Co-founder and President of Insilico Medicine, is set to bring the rapidly evolving science of generative artificial ...
Insilico Medicine has been nominated for the 2026 Prix Galien USA “Best Start-Up” Award in the Biotechnology category, marking the ...
Insilico Medicine founders Dr. Alex Zhavoronkov and Dr. Feng Ren have been invited to the inaugural China Pioneer Innovative Drug ...
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global ...
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, is set to headline BIO Asia-Taiwan 2026, the region’s premier biotechnology ...
In the labyrinthine world of drug discovery, the quest to develop new medications is a marathon marked by thousands of ...
Machine Learning Uncovers New Antibiotics to Combat Resistant Gonorrhea The relentless surge of antibiotic-resistant gonorrhea poses an escalating threat to ...
In a groundbreaking recognition that underscores the rapidly evolving confluence of artificial intelligence and biotechnology, Alex Zhavoronkov, Founder and CEO ...
In the rapidly evolving landscape of therapeutic antibody development, efficiency and precision remain paramount challenges. Antibodies, as cornerstone molecules in ...
In an ambitious leap forward for pharmaceutical science, researchers at the University of Virginia School of Medicine have unveiled a ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine